<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The specific antibody response to Epstein-Barr virus (EBV) antigens of 41 bone marrow transplant recipients with <z:hpo ids='HP_0001909'>leukemia</z:hpo> or <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> was examined retrospectively by immunofluorescence test (IF) over 1 year </plain></SENT>
<SENT sid="1" pm="."><plain>We observed high titers (greater than 640) of IgG-<z:mp ids='MP_0001799'>viral</z:mp> capsid antigen (VCA) with emergence of IgG-early antigen (EA) and frequent absence or low levels of Epstein-Barr nuclear antigen (EBNA) antibodies </plain></SENT>
<SENT sid="2" pm="."><plain>After absorption to remove rheumatoid factor (RF), five of the 41 recipients had IgM-VCA antibody to EBV, which appeared between weeks 26 and 48 after BMT and persisted for 1-4 months </plain></SENT>
<SENT sid="3" pm="."><plain>No heterophil antibodies were detected in these sera, and none of the five recipients had a history of <z:e sem="disease" ids="C0021345" disease_type="Disease or Syndrome" abbrv="">infectious mononucleosis</z:e> </plain></SENT>
</text></document>